Here's a review article on photobiomodulation (aka low level laser therapy [LLLT], 'red light' therapy, LED therapy). It summarizes the peer reviewed, published research on the topic - with emphasis on its use in neurodegenerative diseases and brain injury:
Photobiomodulation and the brain: a new paradigm
ncbi.nlm.nih.gov/pmc/articl...
A clinical trial on photobiomodulation for PD is underway in Australia.* It is curious that some would dismiss outright the possibility of efficacy of photobiomodulation given what has been evidenced heretofore in peer-reviewed, published studies. Certainly it does not seem 'silly' for people to try it out before the trial is completed if they are suffering despite pursuing standard medical treatment.
One caveat is the wavelength that is used. Near infrared light (~810 nm) can penetrate the brain, while red light doesn't penetrate as far into tissue. Some report symptom improvement using light at ~660 nm; perhaps this is a placebo effect or perhaps the therapy is acting more systemically (e.g, causing changes in circulating inflammatory cytokine levels).
* anzctr.org.au/Trial/Registr...
A search of clinicaltrials.gov on photobiomodulation retrieves 85 entries; a search on "low level laser therapy" (quotes are necessary) retrieves 264.